As our understanding of the molecular biology of cancer continues to grow, tumor biomarkers have began to emerge as potential clinical tools. In the present review we will discuss prominent biomarkers in head and neck squamous cell carcinomas (HNSCC). Human papillomavirus (HPV) is the etiology agent in a subgroup of non-smoker, young patients carrying a favorable prognosis. Epidermal growth factor receptor (EGFR) overexpression is commonly present in HNSCC that can be now be targeted by new drugs. The well-known tumor suppressor gene p53 is known to be altered in a vast majority of human cancers. In HNSCC, prognosis is adversely affected by loss of p53. Other markers such as epigenetic alterations, mitochondrial dysfunction, and loss of heterozygosity are addressed in the text. This review emphasizes evidence based diagnostic, staging, monitoring, prognostic, and treatment implications of these biomarkers.
Biological Markers in head and neck cancer
Poeta M. L.;
2009-01-01
Abstract
As our understanding of the molecular biology of cancer continues to grow, tumor biomarkers have began to emerge as potential clinical tools. In the present review we will discuss prominent biomarkers in head and neck squamous cell carcinomas (HNSCC). Human papillomavirus (HPV) is the etiology agent in a subgroup of non-smoker, young patients carrying a favorable prognosis. Epidermal growth factor receptor (EGFR) overexpression is commonly present in HNSCC that can be now be targeted by new drugs. The well-known tumor suppressor gene p53 is known to be altered in a vast majority of human cancers. In HNSCC, prognosis is adversely affected by loss of p53. Other markers such as epigenetic alterations, mitochondrial dysfunction, and loss of heterozygosity are addressed in the text. This review emphasizes evidence based diagnostic, staging, monitoring, prognostic, and treatment implications of these biomarkers.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
